Search

Start typing to see results...

  • Home
  • >
  • Stock Market
  • >
  • Shukra Pharmaceuticals Ltd

Shukra Pharmaceuticals Ltd share price and stock overview

Shukra Pharmaceuticals Ltd (NSE: SHUKRAPHAR, BSE: 524632) operates in the Pharmaceuticals - Indian - Formulations sector. The stock has an ISIN of INE551C01044 and a face value of Rs 1. As of 01 October 2026, it trades at Rs (62.09) with a market capitalisation of Rs 2662.8 crore. Figures are live and subject to change.

Shukra Pharmaceuticals Ltd

Pharmaceuticals - Indian - Formulations
NSE BSE
62.09 1.79 (2.97%) upARrowC
As on: 01-Oct-2026 , 02:51 AM
Market Cap(₹Cr) 2662.8
Book Value(₹Cr) 2.1503968
BSE Code : 524632 NSE Symbol : SHUKRAPHAR EPS(TTM) : 0.82 ISIN Demat : INE551C01044 P/E(TTM) : 73.67 Face Value(₹) : 1 Div & Yield % : 0.02

Today Market

Stock Performance

Today Market

Today's High

73,062.23

Todday's Low

72,366.44

Open at

72,441.15

Previous Close

72,529.07

Volumes

Avg Price

-48.78

Historical Performance

News

04 Sep 26
Shukra Pharmaceuticals Ltd fixes record date for Final dividend
Shukra Pharmaceuticals Ltd fixes record date for Final dividend Record date is 21 September 2026 Shukra Pharmaceuticals Ltd has fixed 21 September 2026 as record date for payment of final dividend of Rs 0.
11 Jun 26
Shukra Pharmaceuticals to conduct EGM
Shukra Pharmaceuticals announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 6 July 2026.
06 Jun 26
Shukra Pharmaceuticals to convene board meeting
Shukra Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 10 June 2026.
08 May 26
Board of Shukra Pharmaceuticals recommends final dividend
Shukra Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 7 May 2026, inter alia, have recommended the final dividend of Rs 0.

Historical Prices

Share Price Chart

Historical Share Price

From Date:
To Date:     
Date Open Price (₹) High Price(₹) Low Price(₹) Close Price(₹) Total Volume No of Trades Net Turnover(₹) NIFTY
30-09-26 60.96 63.36 60.77 62.09 6037718 34756 373692566.91 22620.45
29-09-26 60.25 62.49 59.00 60.30 8970388 51081 542761799.46 22716.20
28-09-26 56.70 60.49 56.00 59.43 15642105 50819 920303373.61 22780.25
25-09-26 56.79 57.28 55.58 55.93 1803626 6966 101337624.47 23140.50
24-09-26 56.40 57.28 55.13 55.76 1524285 7419 85362694.78 23063.10
23-09-26 59.00 59.80 56.00 56.79 3431554 18761 198656767.18 23446.80
22-09-26 55.33 59.40 55.33 58.59 5114278 18173 297449992.89 23329.00
21-09-26 56.00 56.49 55.00 55.33 635277 3184 35287061.70 23414.30
18-09-26 54.76 57.89 54.29 55.93 3423614 9607 191670563.09 23346.40
17-09-26 54.58 55.79 54.06 54.24 2008697 6766 109312823.36 23270.60
123...

Fundamentals

Company Valuation

Market Cap (₹cr)

2662.8

PE Ratio

73.67

PB Ratio

28.09

Dividend Yield

0.02

ROE

28.89

ROCE

36.93

Book Value (₹)

2.1503968

Face Value (₹)

1

Share Holding Pattern

Category of Shareholder No of Shares % Share Holdings Demat Shares Share Holders
plus  Promoter & Group
plus  Foreign
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
plus  Indian
Bodies Corporate-Indian (Promoter & Group) 210250600 47.83 210250600 3
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 14620000 3.33 14620000 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 224870600 51.15 224870600 7
Total ShareHolding for Promoter & Group 224870600 51.15 224870600 7
plus   Publice Share Holding
plus  Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 500000 0.11 500000 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 15000 0.00 15000 1
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 515000 0.12 515000 2
plus  Non Institution
Bodies Corporate 693841 0.16 693831 41
Clearing Members 0 0.00 0 0
Directors & their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 168360852 38.30 168360852 130
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 10936361 2.49 10936361 21
Individuals holding nominal share capital up to Rs. 1 lakh 30120745 6.85 29337075 27930
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 4117041 0.94 4029361 253
Sub Total 214228840 48.73 213357480 28375
Total Public Shareholding 214743840 48.85 213872480 28377
Total of Promoter & Public ShareHolding 439614440 100.00 438743080 28384
plus  Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total 439614440 100.00 438743080 28384

Financials (₹ in cr)

Consolidated Standalone
Year EndMar 2026
Net Sales56.71
OPM (%)50.74
OP28.77
Other Income4.58
PBIDT33.31
INTEREST1.09
PBDT32.22
PBT28.77
EO0.00
PBT after EO28.77
TAXES6.73
PAT22.05
EPS0.50
Raw Material34.30
Power and Fuel0.00
Employee Cost12.41
Other Manufacturing Expenses0.00
Selling and Administration Expenses7.94
Miscellaneous Expenses1.04
Revenue (Growth %) 74.01
PBIDT (Growth %)96.67
PAT (Growth %) 130.26
PBIDT (Margin %)58.74
PAT (Margin %) 38.88

Balance Sheet (₹ in cr)

Particulars (Sources Of Funds)Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Share Capital 43.7943.7910.953.911.571.57
Reserves Total 40.6619.0546.6921.3814.7814.03
Equity Share Warrants5.390.000.000.000.000.00
Equity Application Money0.000.000.000.000.000.00
Total Shareholders Funds89.8462.8457.6425.2916.3515.60
Secured Loans 4.332.701.752.211.100.66
Unsecured Loans 0.691.481.412.872.289.11
Total Debt5.024.183.165.083.389.77
Other Liabilities0.110.130.110.110.000.00
Total Liabilities94.9767.1560.9130.4819.7325.37
APPLICATION OF FUNDS :
Gross Block 49.1943.4240.9739.5735.0733.53
Less : Accumulated Depreciation 27.4724.0321.0219.3317.4915.83
Less:Impairment of Assets0.000.000.000.000.000.00
Net Block 21.7219.3919.9520.2417.5817.70
Lease Adjustment0.000.000.000.000.000.00
Capital Work in Progress11.911.951.661.661.661.66
Producing Properties0.000.000.000.000.000.00
Investments 0.030.000.000.000.000.19
Current Assets, Loans & Advances
Inventories 13.909.952.313.163.951.68
Sundry Debtors 22.958.7724.5130.197.409.75
Cash and Bank Balance5.9212.129.983.970.290.50
Loans and Advances 40.9834.5919.4215.764.234.13
Total Current Assets83.7565.4356.2353.0715.8716.06
Less : Current Liabilities and Provisions
Current Liabilities 13.7213.3412.8741.1912.136.35
Provisions 7.542.890.790.000.000.69
Total Current Liabilities & Provisions21.2616.2213.6641.1912.137.04
Net Current Assets62.4949.2142.5711.883.759.02
Miscellaneous Expenses not written off 0.000.000.000.000.000.00
Deferred Tax Assets2.220.000.000.000.000.00
Deferred Tax Liability3.413.413.273.293.263.20
Net Deferred Tax-1.19-3.41-3.27-3.29-3.26-3.20
Other Assets0.000.000.000.000.000.00
Total Assets94.9667.1460.9030.4819.7325.36
Contingent Liabilities0.000.001.401.401.400.00

Cash Flow (₹ in cr)

Yearly Cash FlowMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Financing Activities -6.684.9412.41-4.524.83
Investing Activities -1.53-4.43-1.20-1.26-14.18
Net Cash Flow -0.213.686.012.14-6.20
Operating Activities 7.993.17-5.207.923.15

Peers

Balance Sheet Financial Ratios Profit & Loss
Accretion Nutrav...

Adline Chem Lab ...

Ajanta Pharma Lt...

3,620.80

(+1.78%)
Amrutanjan Healt...

514.75

(+1.88%)
Bafna Pharmaceut...

371.35

(+1.98%)
BDH Industries L...

Bharat Immunolog...

Bharat Parentera...

1,792.80

(-6.92%)

Corporate Actions

Bonus Dividends Splits
DateCorporate ActionInformation
No Corporate Actions Announced

Board of Directors

Chairman & Chief Executive Officer
DS
Dakshesh Shah
Chairman / Executive Director / Managing Director
Executive
Functional Directors
PM
Payal Mehta
Executive Director
Exec.
DS
Dhruvin Shah
E D & Wholetime Director
Dir.
SP
Sanskruti Patel
E D & Wholetime Director
Dir.
AJP
Anar Jayesh Patel
Executive Director / Whole Time Director / CFO
Exec.
SDS
SHITAL DAKSHESH SHAH
E D & Wholetime Director
Dir.
Independent Directors
PNS
Pinki Nirmal Sagar
Independent Non Exe. Director
Ind.
SDG
Sonal Deepalbhai Gandhi
Independent Non Exe. Director
Ind.
SS
Sarjeevan Singh
Independent Non Exe. Director
Ind.
JS
Jitendra shah
Independent Non Exe. Director
Ind.
RK
Ritu Kapoor
Independent Non Exe. Director
Ind.
Company Secretary & Compliance
SD
Shivkant Dhakad
Company Secretary / Compliance Officer
Sec.

Frequently Asked Questions

What is the NSE symbol and BSE code for Shukra Pharmaceuticals Ltd? −

Shukra Pharmaceuticals Ltd trades on NSE under SHUKRAPHAR and on BSE under code 524632. The ISIN is INE551C01044 and the face value is Rs 1.

What is the share price of Shukra Pharmaceuticals Ltd today? +

As of 01 October 2026, Shukra Pharmaceuticals Ltd trades at Rs 62.09, a change of 1.79 (2.97%) on the day. Prices are live and subject to change.

What is the market capitalisation of Shukra Pharmaceuticals Ltd? +

As of 01 October 2026, Shukra Pharmaceuticals Ltd has a market cap of about Rs 2662.8 crore. This figure is live and moves with the share price.

Is Shukra Pharmaceuticals Ltd profitable? +

In March 2026, Shukra Pharmaceuticals Ltd reported a profit after tax of Rs 22.05 crore. The wording switches to "a net loss of Rs X crore" when the figure is negative.

What is the PE ratio of Shukra Pharmaceuticals Ltd? +

: As of 01 October 2026, the PE (TTM) for Shukra Pharmaceuticals Ltd is 73.67 and the price-to-book ratio is 28.09. When the PE shows zero, state that PE TTM is currently not applicable and give the PB only.

Does Shukra Pharmaceuticals Ltd pay a dividend? +

As of 01 October 2026, the dividend yield for Shukra Pharmaceuticals Ltd is 0.02%. The wording switches to "does not currently pay a dividend" when the yield is zero.

What is the shareholding pattern of Shukra Pharmaceuticals Ltd? +

As of the latest disclosed pattern, promoters hold 51.15% of Shukra Pharmaceuticals Ltd. Public shareholding is 48.85%, including mutual funds at 0.00% and foreign institutional investors at 0.00%.

What were the latest annual financials of Shukra Pharmaceuticals Ltd? +

In March 2026, Shukra Pharmaceuticals Ltd reported net sales of Rs 56.71 crore, revenue growth of 74.01%, and earnings per share of Rs 0.50.